$CGEM
Cullinan Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$11.87
▼-4.96%-$0.620Market open
Cullinan Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CGEM down today? It is at $11.87 (-4.96%), and our scanner flagged it 90 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CGEM spikes, and full due diligence on CGEM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CGEM 90 times in the last 30 days. Create a free account to track $CGEM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CGEM from our scanner (live price and day move above). Fresh from the SEC: Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Michaelson Jennifer Officer | Sold (automatic/other) | -8K 0.01% of company | sold 4.8% | 159K | $173K at $21.57 | Sep 8, 26 |
Michaelson Jennifer Officer | Other | 4K | added 2.5% | 167K | $17K at $4.30 | Sep 8, 26 |
Michaelson Jennifer Officer | Sold (automatic/other) | -30K 0.05% of company | sold 16% | 163K | $608K at $20.26 | Aug 13, 26 |
Michaelson Jennifer Officer | Other | 30K 0.05% of company | added 18% | 193K | $129K at $4.30 | Aug 13, 26 |
Michaelson Jennifer Officer | Sold (automatic/other) | -8K 0.01% of company | sold 4.7% | 163K | $143K at $17.82 | Jul 6, 26 |
Michaelson Jennifer Officer | Other | 4K | added 2.4% | 171K | $17K at $4.30 | Jul 6, 26 |
Fenton Mary Kay Officer | Acquired (grant/award) | +2K | added 1.2% | 128K | $13K at $8.60 | Jun 30, 26 |
Sumer Jacquelyn L Officer | Acquired (grant/award) | +2K | added 1.9% | 131K | $21K at $8.60 | Jun 30, 26 |
Michaelson Jennifer Officer | Sold (automatic/other) | -8K 0.01% of company | sold 4.6% | 167K | $117K at $14.60 | May 5, 26 |
Michaelson Jennifer Officer | Other | 4K | added 2.3% | 175K | $17K at $4.30 | May 5, 26 |
Michaelson Jennifer Officer | Sold (automatic/other) | -8K 0.01% of company | sold 4.5% | 171K | $125K at $15.68 | Mar 5, 26 |
Michaelson Jennifer Officer | Other | 4K | added 2.3% | 179K | $17K at $4.30 | Mar 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CGEM from our scanner (live price and day move above). Fresh from the SEC: Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting. A material company disclosure like this is often the real catalyst behind a move of this size.
CGEM last traded at $11.87, down 4.96% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CGEM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CGEM 90 times in the last 30 days.
CGEM (Cullinan Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $804M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CGEM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CGEM discussion
Sign in to ask a question or join the discussion.